Latest S-1 registration statements
NYSE
American Integrity Insurance Group files amended and restated bylaws, detailing stockholder meeting procedures, director responsibilities, and indemnification policies.
NASDAQ
D. Boral ARC Acquisition I Corp., a blank check company, filed an S-1 registration statement for an initial public offering of 25 million units at $10.00 each, aiming to raise $250 million for a business combination.
NASDAQ
NeOnc Technologies is registering the resale of up to 5.7 million shares of its common stock by existing stockholders following its direct listing on the Nasdaq Global Market.
Churchill Capital Corp X, a blank check company, announces its filing for a $300 million IPO to pursue a merger, share exchange, or asset acquisition with a target business.
AMEX
AZTR
Azitra, INCAzitra Inc. has filed a registration statement for the potential resale of up to 66,889,632 shares of common stock and 6,688,963 shares underlying warrants by Alumni Capital LP, aiming to raise up to $22.6 million for working capital and general corporate purposes.
NASDAQ
Wintergreen Acquisition Corp launches a $50 million IPO targeting technology, media, and telecommunications businesses in the Asia-Pacific region, while navigating regulatory and operational risks tied to China.
NYSE
Spire Global is registering the resale of up to 5,000,000 shares of its Class A common stock by selling stockholders, with the company not receiving any proceeds from the sales.
NASDAQ
AirJoule Technologies Corporation files an amendment to its Form S-1 registration statement relating to the offer and sale of Class A Common Stock by selling stockholders.
NASDAQ
SMTK
Smartkem, INCSmartKem, Inc. has filed an amendment to its Form S-1 registration statement with the SEC, pertaining to the sale of up to 6,402,818 shares of common stock by selling stockholders.
AMEX
S-1: Hyperscale Data Files for S-1 Registration to Resell Shares Upon Conversion of Convertible Notes
Hyperscale Data, Inc. has filed an S-1 registration statement for the resale of up to 29,331,683 shares of Class A common stock issuable upon conversion of certain convertible notes.
Columbus Circle Capital Corp I files for a $200 million IPO to pursue a business combination, offering units consisting of Class A ordinary shares and redeemable warrants.
NASDAQ
S-1: Kochav Defense Acquisition Corp. Files for $220 Million IPO Targeting Defense and Aerospace Sectors
Kochav Defense Acquisition Corp., a newly formed blank check company, aims to raise $220 million through an IPO to pursue acquisitions in the defense and aerospace industries.
NASDAQ
S-1/A: Origin Investment Corp I Files Amended S-1 for $60 Million SPAC IPO Targeting Asia's Growth Sectors
Origin Investment Corp I, a blank check company, filed an amended S-1 registration statement for its initial public offering of 6 million units at $10.00 each, aiming to acquire businesses in Asia's financial services, technology, biotechnology, advanced materials, and clean energy sectors.
AMEX
Pineapple Financial Inc. aims to raise capital through a best-efforts offering of units and pre-funded units, each including common shares or warrants and additional warrants.
NASDAQ
Wrap Technologies has filed a registration statement for the resale of up to 6,433,332 shares of its common stock by selling securityholders, including shares issuable upon exercise of warrants.
NASDAQ
S-1/A: Cantor Equity Partners II, Inc. Files Amendment for $200 Million IPO of Class A Ordinary Shares
Cantor Equity Partners II, Inc. has filed an amendment to its registration statement for a $200 million initial public offering of Class A ordinary shares, with Cantor Fitzgerald & Co. acting as the sole book-running manager.
NASDAQ
SILO
Silo Pharma, INCSilo Pharma launches a public offering of common stock and warrants, aiming to raise approximately $4.3 million for working capital to support its biopharmaceutical development programs.
AgriFORCE Growing Systems has filed an amendment to its registration statement to allow selling stockholders to offer up to 9,698,474 shares of common stock for resale.
OQB
BIO-key International is registering for the resale of up to 3,091,668 shares of its common stock by a selling stockholder, with the company not receiving any proceeds from the sale.
NASDAQ
Altisource Portfolio Solutions S.A. is registering up to 114,499,134 common shares for issuance upon the exercise of stakeholder warrants, aiming to reduce debt and for general corporate purposes.
NYSE
Avidia Bancorp, Inc. is set to offer its common stock for sale in connection with the mutual-to-stock conversion of Assabet Valley Bancorp, aiming for a New York Stock Exchange listing under the symbol AVBC.
NASDAQ
Propanc Biopharma amends its registration statement to offer common stock instead of units, targeting a Nasdaq listing to enhance market visibility.
Cyclacel Pharmaceuticals has filed a registration statement for the potential resale of over 170 million shares of its common stock by selling shareholders.
LTRY
Lotterycom INCLottery.com aims to raise $100 million by registering shares for sale under a stock purchase agreement with Generating Alpha Ltd.
AMEX
Hyperscale Data, Inc. plans to raise up to $50 million through the sale of Series B Preferred Stock, alongside the resale of common stock issuable upon conversion of existing convertible notes.
AMEX
Picard Medical, a medical technology company focused on artificial hearts, has filed an amendment to its S-1 registration statement, signaling progress towards its initial public offering and outlining plans for market expansion and product innovation.
OTC.Pink
Idaho Copper Corporation files an amendment to its registration statement for the potential resale of up to 94.1 million shares of common stock by selling stockholders.
NASDAQ
BriaCell Therapeutics Corp. is registering additional securities for a proposed maximum aggregate offering price not to exceed $5,318,750.
OTC.Pink
Windtree Therapeutics is registering up to 31,247,383 shares of common stock for resale by selling stockholders, including shares issuable upon conversion of preferred stock, exercise of warrants, and under an equity line of credit agreement.
NASDAQ
Intensity Therapeutics is planning a public offering of common stock and warrants to raise capital for clinical trials and general corporate purposes.